149 related articles for article (PubMed ID: 23134557)
21. Malignant evolution of an ACTH-producing pituitary tumor treated with intrasellar implantation of 90Y. Case report and review of the literature.
Papotti M; Limone P; Riva C; Gatti G; Bussolati G
Appl Pathol; 1984; 2(1):10-21. PubMed ID: 6098287
[TBL] [Abstract][Full Text] [Related]
22. Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia.
Haap M; Gallwitz B; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):289-93. PubMed ID: 19085700
[TBL] [Abstract][Full Text] [Related]
23. Transformation of a pituitary macroadenoma into to a corticotropin-secreting carcinoma over 16 years.
Brown RL; Wollman R; Weiss RE
Endocr Pract; 2007 Sep; 13(5):463-71. PubMed ID: 17872347
[TBL] [Abstract][Full Text] [Related]
24. Expression of Ki-67, PCNA, and p27kip1 in canine pituitary corticotroph adenomas.
van Rijn SJ; Grinwis GC; Penning LC; Meij BP
Domest Anim Endocrinol; 2010 May; 38(4):244-52. PubMed ID: 20022446
[TBL] [Abstract][Full Text] [Related]
25. O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas.
Salehi F; Scheithauer BW; Kovacs K; Horvath E; Syro LV; Sharma S; Manoranjan B; Cusimano M
Neurosurgery; 2012 Feb; 70(2):491-6; discussion 496. PubMed ID: 21822153
[TBL] [Abstract][Full Text] [Related]
26. LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASE.
Espinosa-de-Los-Monteros AL; Sosa-Eroza E; Espinosa E; Mendoza V; Arreola R; Mercado M
Endocr Pract; 2017 Jul; 23(7):759-767. PubMed ID: 28332874
[TBL] [Abstract][Full Text] [Related]
27. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
[TBL] [Abstract][Full Text] [Related]
28. Clinically Silent Adrenocorticotropic Hormone-Positive Crooke Cell Adenoma: Case Report and Review of Literature.
Todnem N; Ward A; Segar S; Rojiani AM; Rahimi SY
World Neurosurg; 2018 Nov; 119():197-200. PubMed ID: 30077745
[TBL] [Abstract][Full Text] [Related]
29. Pituitary carcinoma with liver metastases and Cushing syndrome. Report of a case.
Queiroz Lde S; Facure NO; Facure JJ; Modesto NP; Lopes de Faria J
Arch Pathol; 1975 Jan; 99(1):32-5. PubMed ID: 1111493
[TBL] [Abstract][Full Text] [Related]
30. Pituitary pathology in Cushing's disease.
Saeger W; Geisler F; Lüdecke DK
Pathol Res Pract; 1988 Sep; 183(5):592-5. PubMed ID: 3237549
[TBL] [Abstract][Full Text] [Related]
31. [Incidence and clinical manifestation of ACTH-producing pituitary adenoma after bilateral adrenalectomy for Cushing's syndrome (Nelson syndrome)].
Froesch T; Müller J; Labhart A; Froesch ER; Landolt AM
Schweiz Med Wochenschr; 1981 Sep; 111(37):1346-52. PubMed ID: 7291959
[TBL] [Abstract][Full Text] [Related]
32. Management of recurrent and refractory Cushing disease.
Aghi MK
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):560-8. PubMed ID: 18711406
[TBL] [Abstract][Full Text] [Related]
33. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
34. ACTH-producing carcinoma of the pituitary with refractory Cushing's Disease and hepatic metastases: a case report and review of the literature.
Pinchot SN; Sippel R; Chen H
World J Surg Oncol; 2009 Apr; 7():39. PubMed ID: 19356251
[TBL] [Abstract][Full Text] [Related]
35. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E; Maiter D; Grandin C; Raftopoulos C
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[TBL] [Abstract][Full Text] [Related]
36. [A patient with an ACTH-producing pituitary tumor with liver metastasis].
Richter ML; Saeger W; Leifke E; Fahlbusch R; von zur Mühlen A; Schuppert F
Dtsch Med Wochenschr; 2000 Jan; 125(3):52-6. PubMed ID: 10681999
[TBL] [Abstract][Full Text] [Related]
37. Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma?
Lee EJ; Ahn JY; Noh T; Kim SH; Kim TS; Kim SH
Neurosurgery; 2009 Mar; 64(3 Suppl):ons62-9; discussion ons69-70. PubMed ID: 19240574
[TBL] [Abstract][Full Text] [Related]
38. Is Seed and Soil Theory Suitable for Metastatic Spread of Pituitary Carcinomas?
Dai C; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():607405. PubMed ID: 33643220
[No Abstract] [Full Text] [Related]
39. Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis.
Findlay MC; Drexler R; Azab M; Karbe A; Rotermund R; Ricklefs FL; Flitsch J; Smith TR; Kilgallon JL; Honegger J; Nasi-Kordhishti I; Gardner PA; Gersey ZC; Abdallah HM; Jane JA; Marino AC; Knappe UJ; Uksul N; Rzaev JA; Bervitskiy AV; Schroeder HWS; Eördögh M; Losa M; Mortini P; Gerlach R; Antunes ACM; Couldwell WT; Budohoski KP; Rennert RC; Karsy M
World Neurosurg; 2023 Dec; 180():e376-e391. PubMed ID: 37757948
[TBL] [Abstract][Full Text] [Related]
40. Primary pituitary carcinoma: a clinical pathological study.
Nudleman KL; Choi B; Kusske JA
Neurosurgery; 1985 Jan; 16(1):90-5. PubMed ID: 3974820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
